Kikuchi, Shohei
Harvard University · Dana-Farber Cancer Institute · Dana-Farber/Harvard Cancer Center
4 papers on CoChatORCID 0000-0002-0961-6253
Most cited papers
- Verified
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
Görgün, G., Samur, M. K., Cowens, K. B., Paula, S., Bianchi, G., Anderson, J. E., White, R. E., Singh, A., Ohguchi, H., Suzuki, R., et al. (2015) · Clinical Cancer Research
Multiple Myeloma Research and TreatmentsCancer Immunotherapy and Biomarkers
Cited by 309
- Verified
HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications
Harada, T., Ohguchi, H., Grondin, Y., Kikuchi, S., Sagawa, M., Tai, Y.-T., Mazitschek, R., Hideshima, T., & Anderson, K. C. (2017) · Leukemia
Histone Deacetylase Inhibitors ResearchMultiple Myeloma Research and Treatments
Cited by 89
- Verified
Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox
Kikuchi, S., Kobune, M., Iyama, S., Sato, T., Murase, K., Kawano, Y., Takada, K., Ono, K., Kaneko, Y., Miyanishi, K., et al. (2012) · Free Radical Biology and Medicine
Iron Metabolism and DisordersAcute Myeloid Leukemia Research
Cited by 56
- Verified
The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma
Kamihara, Y., Takada, K., Sato, T., Kawano, Y., Murase, K., Arihara, Y., Kikuchi, S., Hayasaka, N., Usami, M., Iyama, S., et al. (2016) · Oncotarget
Multiple Myeloma Research and TreatmentsIron Metabolism and Disorders
Cited by 45
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free